Product Details
| Product Name:
Utibapril |
CAS No.:
109683-61-6 |
| Supply Ability:
10g |
Release date:
2025/07/18 |
Product Introduction
Bioactivity
| Name | Utibapril |
| Description | Utibapril, an inhibitor of angiotensin-converting enzyme (ACE), exhibits antihypertensive activities. |
| In vivo | Utibapril significantly inhibits plasma, renal, and vascular ACE but not ventricular ACE activity. Vascular ACE activity is significantly inhibited by Utibapril (2 μg/kg/day), and Utibapril (250 μg/kg/day) results in significant inhibition of plasma ACE. Additionally, angiotensin I-induced decreases in coronary flow in the isolated heart are significantly inhibited after treatment with higher doses of Utibapril [1]. FPL 63547 is rapidly and extensively excreted as the diacid in bile but appears in urine in negligible amounts [2]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Keywords | FPL63547 | FPL-63547 | Utibapril |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries， 10000+ Noval Small Molecucles，16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$2500.00
|
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-05-11 |
United States